Latest Breaking News On - Obseva executive committee - Page 1 : comparemela.com

Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 8, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical.

Plan les ouatesFranche comtérCatarina edfjLuigi marroMerck seronoErnest loumayeEconomical statistic sciencesArticles of associationCompensation committeeMaster of business administrationSwiss exchangeUniversity in lyonObseva executive committeeCommittee for the fiscal yearVoisin life sciences consultingStrategy development

ObsEva SA: Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland - June 8, 2023 - ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for

Mecklenburg vorpommernPlan les ouatesFranche comtérErnest loumayeMerck seronoStefan klotterLuigi marroCatarina edfjMaster of business administrationCompensation committeeEconomical statistic sciencesArticles of associationStrategy developmentVoisin life sciences consultingCommittee for the fiscal yearObseva executive committee

ObsEva SA: ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - May 2, 2023 - ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's

Ernest loumayeShauna dillonWill brownUniversity in lyonSwiss exchangeObseva executive committeeFabien de ladonchampsChief executive officerInterim chief executive officerChief financialExecutive committeeInterim chairmanChief executiveChief administrative officerInterim chief financialAddex therapeutics

ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer

ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ernest loumayeWill brownShauna dillonUniversity in lyonObseva executive committeeSwiss exchangeFabien de ladonchampsChief executive officerInterim chief executive officerChief financialExecutive committeeInterim chairmanChief executiveChief administrative officerInterim chief financialAddex therapeutics

ObsEva SA: ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - March 13, 2023 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing

Dennis riedlErnest loumayeShauna dillonAnnette clancyObseva executive committeeUniversity in lyonSwiss exchangeInterim chairmanGeneral meetingFabien de ladonchampsChief executive officerExecutive committeeChief administrative officerInterim chief financialAddex therapeuticsInterim chief executive officer